Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema (unspecified eye)
ICD-10 E10.3319 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema (unspecified eye).
E10.3319 refers to a specific condition in patients with Type 1 diabetes mellitus characterized by moderate nonproliferative diabetic retinopathy (NPDR) accompanied by macular edema in an unspecified eye. Type 1 diabetes is an autoimmune condition leading to the destruction of insulin-producing beta cells in the pancreas, resulting in absolute insulin deficiency. Diabetic retinopathy is a common complication of diabetes, where high blood sugar levels damage the blood vessels in the retina. Moderate NPDR indicates the presence of microaneurysms, retinal hemorrhages, and exudates, but without the severe complications seen in proliferative diabetic retinopathy. Macular edema, a result of fluid accumulation in the macula, can lead to vision impairment. Management of this condition often involves strict glycemic control, with HbA1c levels ideally maintained below 7% to prevent further retinal damage. Insulin therapy is crucial for Type 1 diabetes management, and regular ophthalmologic evaluations are essential for early detection and treatment of retinopathy.
Detailed records of diabetes management, including insulin regimen and HbA1c levels.
Patients presenting with uncontrolled diabetes and complications.
Ensure documentation reflects the relationship between diabetes control and retinopathy.
Comprehensive eye examination reports detailing findings of retinopathy and macular edema.
Routine diabetic eye exams showing progression of retinopathy.
Document the specific eye affected and the severity of findings.
Used during routine eye exams for diabetic patients.
Document findings of retinopathy and any treatment plans.
Ophthalmologists should ensure detailed documentation of retinal findings.
Specifying the eye affected is crucial for accurate diagnosis and treatment planning, as it impacts management strategies and potential interventions.
